Abrogation of PMCA4 did not significantly alter the numbers of activated (antigen-experienced) CD4+ and CD8+ T cells (as defined by upregulation and co-expression of CD11a and CD49d [32, 33];) in the spleen on day 7 of infection. This evidence concerns the gene CD8A and infection.